BSE filing, NSE: SYMBIOX. Summary written from the filing by ALFA Finder's alert engine.
Symbiox Investment & Trading Co. Ltd: key numbers
- Share price
- ₹1.50
- Market cap
- ₹4.69 Cr
- Revenue (annual)
- ₹1.60 Cr
- Net profit (annual)
- ₹0.15 Cr
- P/E (TTM)
- 28.9×Sector 19.7×
- Promoter holding
- 3.33%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Symbiox Investment & Trading Co. Ltd
All →Symbiox Investment & Trading Co Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) as mandated by SEBI regulations. This filing contains no material business events or corporate transactions.
Symbiox Investment & Trading Co Annual General Meeting
Symbiox Investment & Trading Company Ltd held its 47th Annual General Meeting on September 28, 2026. Shareholders adopted audited financial statements and re-appointed Mrs. Sunita Show as Director.
Symbiox Investment & Trading Company Annual Report
Symbiox Investment & Trading Company Ltd submitted its 47th Annual Report for the financial year 2025-26. The report includes the notice for the upcoming Annual General Meeting.
Symbiox Investment & Trading Co Annual General Meeting
Symbiox Investment & Trading Company Ltd will hold its 47th Annual General Meeting on September 28, 2026. The agenda includes adopting FY26 financial statements and director re-appointment.
Symbiox Investment & Trading Co Annual General Meeting
Symbiox Investment & Trading Co. Ltd announced its 47th Annual General Meeting for September 28, 2026. The board approved the director's report and e-voting schedules.
Symbiox Investment & Trading Co Board Meeting Date
Symbiox Investment & Trading Co. Ltd. will hold a Board Meeting on August 26, 2026. The agenda includes approving the Director Report and scheduling the AGM.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.